Abstract:Abstract Background : Integrin is a vital cell membrane surface receptor that conducts bidirectional signal transduction across the cell membrane and regulates cell adhesion and activation. Integrin β8 (ITGβ8) belongs to the β subunit family of integrin. It is a tumour promoter and its levels are upregulated in various cancers, including non-small-cell lung cancer (NSCLC). However, a comprehensive analysis of its prognostic value in NSCLC has not been performed. Here, bioinformatics analysis and basic experiments were used to investigated the expression of ITGβ8 in NSCLC and its potential association with immunotherapy. Methods : In this study, we used bioinformatics technology to analyze not only the expression of ITGβ8 in NSCLC tissues in the database, but also the correlation between ITGβ8 expression and immune cell infiltration, immune checkpoint expression, TMB expression, signaling pathways and patient survival. The expression of ITGβ 8 in NSCLC cells was verified by WB and RT-qPCR. Kaplan-Meier survival curves were used to analyze the relationship between ITGβ8 expression levels and prognosis of NSCLC patients. Log-rank test and cox proportional-hazards model were used to identify risk factors associated with prognosis. Results :The TCGA database and HPA database as well as our lung cancer tissue specimens showed high expression of ITGβ8 in NSCLC tumor tissues. ITGβ8 was highly expressed in lung cancer cell lines compared to normal lung epithelial cell lines. Bioinformatics technology analysis demonstrated that ITGβ8 expression correlated with immune subtypes, immune infiltrating cells, immune checkpoint genes, and signaling pathways. High expression of ITGβ8 in NSCLC has a shorter survival. Kaplan-Meier survival curve and cox regression analysis demonstrated that increased ITGβ8 expression was a marker of poor prognosis in NSCLC, and its expression level was positively correlated with lymph node metastasis and TNM stage. Conclusions : ITGβ8 is highly expressed in NSCLC, and it is involved in regulating the immune process of NSCLC. It may be an important immune predictive biomarker that provides a new idea for the treatment of NSCLC.

The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis

The effect of BTG1 expression on proliferation, apoptosis and invasion of non-small cell lung cancer cells

BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial–Mesenchymal Transition

B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis

Epigenetic Downregulated ITGBL1 Promotes Non-Small Cell Lung Cancer Cell Invasion Through Wnt/PCP Signaling

Btg1 Expression Correlates With The Pathogenesis And Progression Of Ovarian Carcinomas

BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1.

Plasma exosome-derived B-cell translation gene 1: a predictive marker for the prognosis in patients with non-small cell lung cancer

Btg1 Inhibits Breast Cancer Cell Growth Through Induction Of Cell Cycle Arrest And Apoptosis

Expression of BTG1 in HK-2 and 786-O and Its Influence on Cell Cycle and Apoptosis of HK-2 and 786-O

Interfering with ITGB1-DT expression delays cancer progression and promotes cell sensitivity of NSCLC to cisplatin by inhibiting the MAPK/ERK pathway

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer

P3.16-01 A Multi-Omic Study Reveals BTG2 As a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

TGIF1 Promoted the Growth and Migration of Cancer Cells in Nonsmall Cell Lung Cancer

Downregulation of Guanine Nucleotide-Binding Protein Beta 1 (GNB1) is Associated with Worsened Prognosis of Clearcell Renal Cell Carcinoma and is Related to VEGF Signaling Pathway.

B-Cell Translocation Gene 2 Upregulation is Associated with Favorable Prognosis in Lung Adenocarcinoma and Prolonged Patient Survival

Regulation of BTG3 by Microrna-20B-5p in Non-Small Cell Lung Cancer.

Expression of BTG1 in Renal Clear Cell Carcinoma and Its Role in 786-O Cell Proliferation and Apoptosis in Vitro

What is the impact of ITGβ8 on NSCLC: A systematic study